吸引力
发表于 2025-3-26 22:39:52
Immunosuppression with Limited Toxicity: The Characteristics of Nucleoside Analogs and Anti-Lymphoca particularly potent cytokine-release syndrome. Although fludarabine has been the mainstay of nucleoside analog usage for NST, the other nucleoside analogs-cladribine and pentostatin are beginning to be investigated in this context.
北极熊
发表于 2025-3-27 02:20:27
http://reply.papertrans.cn/67/6670/666976/666976_32.png
amputation
发表于 2025-3-27 05:55:31
http://reply.papertrans.cn/67/6670/666976/666976_33.png
纤细
发表于 2025-3-27 12:00:44
Non-Myeloablative Allogeneic Hematopoietic Transplantation and Induction of Graft-Versus-Malignancy diseases such as chronic myelogenous leukemia (CML) which may take six to twelve months after transplant presumably due to an ongoing graft-versus-leukemia effect.. Withdrawal of immunosuppression given for prevention of GVHD can occasionally lead to restoration of remission in patient relapsing af
Extort
发表于 2025-3-27 16:37:53
,Outpatient Allografting in Hematologic Malignancies and Nonmalignant Disorders — Applying Lessons Luggest that mixed chimerism can partially correct the phenotypic expression of disease, but that complete chimerism will be necessary to halt the continued hemolytic process of the host type minority red blood cell population. In contrast, mixed chimerism would be expected to correct disease manifes
天然热喷泉
发表于 2025-3-27 20:01:16
Non-Myeloablative Transplants for Congenital Diseases,e both in animal studies as well as in clinical trials. By using well-designed murine models such as the β-thalassemic mouse outlined above, we believe we can determine the optimal conditions for non-myeloablative postnatal transplants with allogeneic or haplocompatible HSC following prenatal tolera
他去就结束
发表于 2025-3-28 01:17:39
0927-3042usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.978-1-4613-5304-1978-1-4615-0919-6Series ISSN 0927-3042 Series E-ISSN 2509-8497
bourgeois
发表于 2025-3-28 03:29:07
http://reply.papertrans.cn/67/6670/666976/666976_38.png
艰苦地移动
发表于 2025-3-28 07:27:41
Book 2002or advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunother
是突袭
发表于 2025-3-28 13:33:45
http://reply.papertrans.cn/67/6670/666976/666976_40.png